NASDAQ:CEMI Chembio Diagnostics (CEMI) Stock Price, News & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.45▼$0.4650-Day Range$0.33▼$0.4652-Week Range$0.19▼$1.24Volume351,642 shsAverage Volume661,416 shsMarket Capitalization$16.71 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Chembio Diagnostics alerts: Email Address Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here About Chembio Diagnostics Stock (NASDAQ:CEMI)Chembio Diagnostics, Inc. engages in the developing, manufacturing, marketing, and licensing of rapid medical tests. It offers rapid point-of-care tests for infectious, tropical and fever, and respiratory diseases, handheld analyzers, and veterinary products. The firm distributes its products to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. The company was founded in 1985 and is headquartered in Medford, NY.Read More Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here CEMI Stock News HeadlinesApril 17, 2024 | finance.yahoo.comANY LAB TEST NOW Forms Strategic Partnership with ChembioNovember 2, 2023 | morningstar.comQuest Diagnostics Inc DGXJuly 27, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.July 24, 2023 | marketwatch.comQualigen Therapeutics Sells FastPack Diagnostics Business to ChembioApril 27, 2023 | finance.yahoo.comBiosynex Completes Acquisition of Chembio Diagnostics, Inc.April 27, 2023 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Laboratory (LH), Arbutus Biopharma (ABUS) and Chembio Diagnostics (CEMI)April 20, 2023 | benzinga.comShareholder Alert: Ademi LLP investigates whether Chembio Diagnostics, Inc. has obtained a Fair Price in its transaction with BiosynexApril 19, 2023 | finance.yahoo.comChembio Stockholders Urged to Tender Shares Before 6:00 P.M., New York City Time, on April 26, 2023July 27, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.April 14, 2023 | msn.comChembio Diagnostics And 2 Other Stocks Under $1 Insiders Are Aggressively BuyingApril 10, 2023 | finance.yahoo.comChembio Stockholders Reminded to Tender Shares Before 6:00 P.M., New York City Time, on April 12, 2023April 3, 2023 | finance.yahoo.comChembio’s CEO Letter to StockholdersMarch 21, 2023 | finance.yahoo.comChembio Stockholders Reminded to Tender Shares Before 6:00 PM New York City Time, on March 28, 2023March 15, 2023 | finance.yahoo.comBiosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.March 15, 2023 | finance.yahoo.comChembio Announces Letter to Stockholders Regarding Tender OfferFebruary 24, 2023 | finance.yahoo.comChembio Announces the Receipt of CLIA Waiver for its DPP HIV-Syphilis SystemFebruary 8, 2023 | benzinga.comMoore Kuehn Encourages ALBO, LPTX, ALR, and CEMI Investors to Contact Law FirmFebruary 2, 2023 | wsj.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Chembio Diagnostics, Inc. BuyoutSee More Headlines Receive CEMI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Chembio Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/04/2021Today7/27/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:CEMI CUSIPN/A CIK1092662 Webwww.chembio.com Phone(631) 924-1135Fax631-924-2065Employees337Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.20) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-23,290,000.00 Net Margins-47.03% Pretax Margin-46.96% Return on Equity-113.57% Return on Assets-38.22% Debt Debt-to-Equity RatioN/A Current Ratio1.23 Quick Ratio1.04 Sales & Book Value Annual Sales$48.34 million Price / Sales0.35 Cash FlowN/A Price / Cash FlowN/A Book Value$0.48 per share Price / Book0.95Miscellaneous Outstanding Shares36,726,000Free Float35,514,000Market Cap$16.71 million OptionableNot Optionable Beta1.85 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesRichard L. EberlyPresident, Chief Executive Officer & DirectorPaul J. AngelicoChief Operations Officer & Executive VPLawrence J. SteenvoordenChief Financial Officer, Secretary & Executive VPJavan EsfandiariExecutive VP, Chief Science & Technology OfficerAtif RizviVice President-FinanceKey CompetitorsOrgenesisNASDAQ:ORGSViveon Health AcquisitionNYSE:VHAQBioLineRxNASDAQ:BLRXMediciNovaNASDAQ:MNOVAnebulo PharmaceuticalsNASDAQ:ANEBView All Competitors CEMI Stock Analysis - Frequently Asked Questions How were Chembio Diagnostics' earnings last quarter? Chembio Diagnostics, Inc. (NASDAQ:CEMI) announced its quarterly earnings results on Thursday, November, 4th. The company reported ($0.24) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.19) by $0.05. The firm earned $12.06 million during the quarter. Chembio Diagnostics had a negative trailing twelve-month return on equity of 113.57% and a negative net margin of 47.03%. What other stocks do shareholders of Chembio Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Chembio Diagnostics investors own include Prospect Capital (PSEC), Calumet Specialty Products Partners (CLMT), Two Harbors Investment (TWO), BlackRock Capital Investment (BKCC), NovoCure (NVCR), Viper Energy (VNOM) and Summit Midstream Partners (SMLP). This page (NASDAQ:CEMI) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal war...Behind the Markets | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chembio Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Chembio Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.